TAK News and Press, Takeda Pharmaceutical Company Limited American Depositary Shares From 12/07/23

2023-12-07 23:57:14 ET Summary MoonLake Therapeutics is a clinical-stage biopharmaceutical company developing nanobody-based therapies for inflammatory diseases. Their lead product candidate, Sonelokimab, has shown best-in-class potential in treating Hidradenitis suppurativa and P...

2023-12-07 03:04:44 ET Japan ( NKY:IND ) -1.76%. The index of coincident economic indicators in Japan, which covers a range of data, such as factory output, employment, and retail sales, ticked higher to 115.9 in October 2023 from an upwardly revised 115.7 in the prior mo...

2023-12-06 02:42:19 ET Japan ( NKY:IND ) +2.04% . The Reuters Tankan sentiment index for manufacturers in Japan jumped to +12 in December 2023 from +6 in November, improving for the second straight month. China ( SHCOMP ) -0.09% . Investors now look a...

2024 Award Celebrates Outstanding Research in Cancer Immunology Winners Discovered Novel Connections Between the Immune System and Cancer Recipients Each Receive Unrestricted USD 200,000 Awards Takeda ( TSE:4502/NYSE:TAK ) and The New York Academy of Sciences today...

2023-12-05 02:59:08 ET More on Asia EWJ: Growth Story Emerges But Major Monetary Issues Remain China's industrial profits continue to shrink in November at slower pace Japanese yen gains as Bank of Japan is poised to tweak yield-curve control - report Asi...

2023-12-04 02:24:58 ET More on Asia Bank of Japan: Last Man Standing With Negative Interest Rate Policy - May End Soon Japan's factory activity contracts for the sixth straight month in November For further details see: Asian markets mixed as investors look ahead...

2023-11-29 13:38:43 ET More on Aeglea BioTherapeutics Aeglea Biotherapeutics announces name change to Spyre Therapeutics Aeglea BioTherapeutics announces 1-for-25 reverse stock split Seeking Alpha’s Quant Rating on Aeglea BioTherapeutics Historical ear...

2023-11-29 02:49:33 ET Japan ( NKY:IND ) -0.26% . Japan’s 10-year government bond yield fell below 0.7%, sliding to its lowest levels in nearly three months. Markets also look ahead to key economic data this week, with Japanese retail sales and industrial produc...

2023-11-28 12:33:17 ET Summary Ascendis Pharma A/S reported strong sequential growth of Skytrofa and raised its full-year net sales guidance range. The NDA resubmission for TransCon PTH is expected by mid-November, with FDA feedback by mid-December and a potential PDUFA date in Ja...

2023-11-27 17:41:15 ET Summary ImmunoGen, Inc. expects to convert the Accelerated Approval of its drug Elahere to "Full Approval" in the 1st half of 2024. Potential European approval of Elahere for treatment of patients with FRa-high platinum-resistant ovarian cancer expected late...